GO Term |
GO Name |
Enriched Genes |
Log10 Adjusted P-value |
[BP] GO:1901700 |
response to oxygen-containing compound
|
AKR1B1, ALPL, APP, BCL2, CA9, CDK6, CSNK2A1, CYP1A1, CYP1A2, CYP1B1, DRD1, DRD2, EGFR, ESR1, ESRRA, FABP3, HSD11B2, HSD17B2, IGF1R, INSR, MMP2, MMP9, PPARA, RORC, SRC, TEK, TYR |
10.5828 |
[BP] GO:0006629 |
lipid metabolic process
|
ACHE, ADORA1, AKR1B1, AKR1B10, ALOX15, APP, CBR1, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP3A4, DRD2, EGFR, ESR1, FABP3, FABP4, FUT7, GBA2, HSD11B1, HSD11B2, HSD17B1, HSD17B2, MET, PPARA |
10.3444 |
[BP] GO:0010033 |
response to organic substance
|
AKR1B1, ALOX15, ALPL, APP, BCL2, CA2, CA9, CDK6, CSNK2A1, CYP1A1, CYP1A2, CYP1B1, DRD1, DRD2, EGFR, ESR1, ESRRA, FABP3, FABP4, HSD11B2, HSD17B2, HSPA1A, IGF1R, INSR, KDR, MMP2, PPARA, RORC, SMAD3, SRC, TEK, TYR |
10.3444 |
[BP] GO:0008152 |
metabolic process
|
ACHE, ADORA1, AKR1B1, AKR1B10, ALOX15, ALPL, AOX1, APP, BCL2, CA1, CA12, CA2, CA4, CA6, CA7, CA9, CBR1, CDC25B, CDK6, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP3A4, DRD1, DRD2, DUSP3, EGFR, ESR1, ESR2, ESRRA, ESRRB, F10, F3, FABP3, FABP4, FUT7, GBA2, HSD11B1, HSD11B2, HSD17B1, HSD17B2, HSPA1A, IGF1R, INSR, KDR, MET, MMP1, MMP2, MMP9, NUAK1, PPARA, PTPN1, PTPRS, RORC, SMAD3, SRC, TEK, TNKS, TNKS2, TYR, XDH |
9.60925 |
[BP] GO:0065008 |
regulation of biological quality
|
ABCB1, ACHE, ADORA1, AKR1B1, ALOX15, APP, BCL2, CA12, CA2, CA7, CDK6, CYP19A1, CYP1A1, CYP1B1, CYP3A4, DRD1, DRD2, EGFR, ESR1, F10, F3, FABP3, FABP4, GPR35, HSD11B1, HSD11B2, HSD17B1, HSD17B2, HSPA1A, INSR, KDR, MET, PPARA, SMAD3, SRC, TEK, TNKS, TNKS2, XDH |
9.54444 |
[BP] GO:0042221 |
response to chemical
|
ABCB1, AKR1B1, ALOX15, ALPL, APP, BCL2, CA2, CA9, CDK6, CSNK2A1, CYP1A1, CYP1A2, CYP1B1, DRD1, DRD2, EGFR, ESR1, ESRRA, FABP3, FABP4, HSD11B2, HSD17B2, HSPA1A, IGF1R, INSR, KDR, MMP2, MMP9, PPARA, RORC, SMAD3, SRC, TEK, TYR |
9.54444 |
[BP] GO:0008202 |
steroid metabolic process
|
AKR1B1, AKR1B10, APP, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP3A4, ESR1, GBA2, HSD11B1, HSD11B2, HSD17B1, HSD17B2 |
9.54444 |
[BP] GO:0010647 |
positive regulation of cell communication
|
ADORA1, AKR1B1, ALOX15, APP, BCL2, CA2, CA7, CSNK2A1, CYP19A1, CYP1B1, DRD1, DRD2, EGFR, F10, F3, GPR35, HSPA1A, INSR, KDR, MET, MMP9, PTPN1, SMAD3, SRC, TEK, TNKS, TNKS2, XDH |
9.21938 |
[BP] GO:0023056 |
positive regulation of signaling
|
ADORA1, AKR1B1, ALOX15, APP, BCL2, CA2, CA7, CSNK2A1, CYP19A1, CYP1B1, DRD1, DRD2, EGFR, F10, F3, GPR35, HSPA1A, INSR, KDR, MET, MMP9, PTPN1, SMAD3, SRC, TEK, TNKS, TNKS2, XDH |
9.20883 |
[BP] GO:0015701 |
bicarbonate transport
|
CA1, CA12, CA14, CA2, CA4, CA6, CA7, CA9 |
8.41531 |
[BP] GO:2000145 |
regulation of cell motility
|
ADORA1, ADORA3, APP, BCL2, CDK6, CYP19A1, CYP1B1, DRD1, DRD2, EGFR, F10, F3, IGF1R, INSR, KDR, MET, MMP9, SMAD3, SRC, TEK |
8.25747 |
[BP] GO:0014070 |
response to organic cyclic compound
|
ALPL, APP, BCL2, CA2, CA9, CSNK2A1, CYP1A1, CYP1A2, CYP1B1, DRD1, DRD2, EGFR, ESR1, ESRRA, HSD11B2, RORC, SRC, TEK, TYR |
8.25747 |
[BP] GO:0009719 |
response to endogenous stimulus
|
AKR1B1, ALPL, APP, BCL2, CA2, CA9, CSNK2A1, CYP1A2, DRD1, EGFR, ESR1, ESRRA, FABP3, HSD11B2, IGF1R, INSR, MMP2, PPARA, SMAD3, SRC, TEK |
7.83735 |
[BP] GO:0030334 |
regulation of cell migration
|
ADORA1, ADORA3, APP, BCL2, CYP19A1, CYP1B1, DRD1, DRD2, EGFR, F10, F3, IGF1R, INSR, KDR, MET, MMP9, SMAD3, SRC, TEK |
7.83628 |
[BP] GO:0042127 |
regulation of cell proliferation
|
ADORA1, ADORA3, AKR1B1, APP, BCL2, CDC25B, CDK6, CSNK2A1, CYP1B1, DRD2, EGFR, ESR1, ESRRA, F3, FABP3, HSPA1A, IGF1R, INSR, KDR, MMP2, MMP9, NUAK1, SMAD3, SRC, TEK, XDH |
7.77076 |
[BP] GO:0040012 |
regulation of locomotion
|
ADORA1, ADORA3, APP, BCL2, CDK6, CYP19A1, CYP1B1, DRD1, DRD2, EGFR, F10, F3, IGF1R, INSR, KDR, MET, MMP9, SMAD3, SRC, TEK |
7.77076 |
[BP] GO:0051270 |
regulation of cellular component movement
|
ADORA1, ADORA3, APP, BCL2, CDK6, CYP19A1, CYP1B1, DRD1, DRD2, EGFR, F10, F3, IGF1R, INSR, KDR, MET, MMP9, SMAD3, SRC, TEK |
7.77076 |
[BP] GO:0044237 |
cellular metabolic process
|
ACHE, AKR1B1, AKR1B10, ALOX15, ALPL, AOX1, APP, BCL2, CA1, CA12, CA2, CA4, CA6, CA7, CA9, CBR1, CDC25B, CDK6, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP3A4, DRD1, DRD2, DUSP3, EGFR, ESR1, ESR2, ESRRA, ESRRB, F10, FABP3, FABP4, FUT7, GBA2, HSD17B1, HSD17B2, HSPA1A, IGF1R, INSR, KDR, MET, MMP1, MMP2, NUAK1, PPARA, PTPN1, PTPRS, RORC, SMAD3, SRC, TEK, TNKS, TNKS2, TYR, XDH |
7.64261 |
[BP] GO:0006730 |
one-carbon metabolic process
|
CA1, CA12, CA2, CA4, CA6, CA7, CA9 |
7.48527 |
[BP] GO:0042445 |
hormone metabolic process
|
ACHE, AKR1B1, CYP19A1, CYP1A1, CYP1B1, CYP3A4, ESR1, HSD11B1, HSD11B2, HSD17B1, HSD17B2 |
7.43336 |
[BP] GO:0048522 |
positive regulation of cellular process
|
ACHE, ADORA1, AKR1B1, ALOX15, APP, BCL2, CA2, CA7, CDC25B, CDK6, CSNK2A1, CYP19A1, CYP1A1, CYP1B1, DRD1, DRD2, DUSP3, EGFR, ESR1, ESR2, ESRRA, ESRRB, F10, F3, FABP3, GPR35, HSPA1A, IGF1R, INSR, KDR, MET, MMP1, MMP2, MMP9, PPARA, PTPN1, RORC, SMAD3, SRC, TEK, TNKS, TNKS2, XDH |
7.11362 |
[BP] GO:0032502 |
developmental process
|
ACHE, ADORA1, AKR1B1, ALOX15, ALPL, APP, BCL2, CA2, CA9, CBR1, CDC25B, CDK6, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, DRD1, DRD2, DUSP3, EGFR, ESR1, ESRRA, ESRRB, FABP4, FUT7, GBA2, HSD11B1, HSD17B2, INSR, KDR, MET, MMP2, MMP9, PPARA, PTPRS, RORC, SMAD3, SRC, TEK, TNKS2, TYR |
7.05068 |
[BP] GO:0009967 |
positive regulation of signal transduction
|
ADORA1, AKR1B1, ALOX15, APP, BCL2, CSNK2A1, CYP1B1, DRD2, EGFR, F10, F3, GPR35, HSPA1A, INSR, KDR, MET, MMP9, PTPN1, SMAD3, SRC, TEK, TNKS, TNKS2, XDH |
7.00516 |
[BP] GO:0010646 |
regulation of cell communication
|
ACHE, ADORA1, AKR1B1, ALOX15, APP, BCL2, CA2, CA7, CSNK2A1, CYP19A1, CYP1B1, DRD1, DRD2, DUSP3, EGFR, ESR1, ESR2, F10, F3, GPR35, HSPA1A, IGF1R, INSR, KDR, MET, MMP9, NUAK1, PTPN1, PTPRS, SMAD3, SRC, TEK, TNKS, TNKS2, XDH |
6.89025 |
[BP] GO:0048856 |
anatomical structure development
|
ACHE, ADORA1, AKR1B1, ALOX15, ALPL, APP, BCL2, CA2, CDK6, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, DRD1, DRD2, DUSP3, EGFR, ESR1, ESRRA, ESRRB, GBA2, HSD11B1, HSD17B2, INSR, KDR, MMP9, PPARA, PTPRS, RORC, SMAD3, SRC, TEK, TYR |
6.80811 |
[BP] GO:0023051 |
regulation of signaling
|
ACHE, ADORA1, AKR1B1, ALOX15, APP, BCL2, CA2, CA7, CSNK2A1, CYP19A1, CYP1B1, DRD1, DRD2, DUSP3, EGFR, ESR1, ESR2, F10, F3, GPR35, HSPA1A, IGF1R, INSR, KDR, MET, MMP9, NUAK1, PTPN1, PTPRS, SMAD3, SRC, TEK, TNKS, TNKS2, XDH |
6.78302 |
[BP] GO:0044281 |
small molecule metabolic process
|
AKR1B1, AKR1B10, ALOX15, AOX1, APP, CA1, CA12, CA2, CA4, CA6, CA7, CA9, CBR1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP3A4, FABP3, FUT7, GBA2, HSPA1A, PPARA, TYR, XDH |
6.75004 |
[BP] GO:0048583 |
regulation of response to stimulus
|
ABCB1, ADORA1, AKR1B1, ALOX15, APP, BCL2, CDK6, CSNK2A1, CYP19A1, CYP1B1, DRD1, DRD2, DUSP3, EGFR, ESR1, ESR2, ESRRA, F10, F3, FABP4, GPR35, HSPA1A, IGF1R, INSR, KDR, MET, MMP2, MMP9, NUAK1, PPARA, PTPN1, PTPRS, SMAD3, SRC, TEK, TNKS, TNKS2, XDH |
6.69622 |
[BP] GO:0033993 |
response to lipid
|
ALPL, BCL2, CA2, CA9, CDK6, CSNK2A1, CYP1A1, CYP1A2, EGFR, ESR1, ESRRA, FABP3, HSD11B2, HSD17B2, RORC, SRC, TYR |
6.69622 |
[BP] GO:0048518 |
positive regulation of biological process
|
ABCB1, ACHE, ADORA1, AKR1B1, ALOX15, APP, BCL2, CA2, CA7, CDC25B, CDK6, CSNK2A1, CYP19A1, CYP1A1, CYP1B1, DRD1, DRD2, DUSP3, EGFR, ESR1, ESR2, ESRRA, ESRRB, F10, F3, FABP3, FABP4, GPR35, HSPA1A, IGF1R, INSR, KDR, MET, MMP1, MMP2, MMP9, PPARA, PTPN1, RORC, SMAD3, SRC, TEK, TNKS, TNKS2, XDH |
6.69622 |
[BP] GO:0030335 |
positive regulation of cell migration
|
APP, BCL2, DRD1, EGFR, F10, F3, IGF1R, INSR, KDR, MET, MMP9, SMAD3, SRC, TEK |
6.6961 |
[BP] GO:0048513 |
animal organ development
|
ACHE, BCL2, CA2, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, EGFR, ESR1, ESRRA, ESRRB, HSD11B1, HSD17B2, INSR, KDR, PPARA, PTPRS, SMAD3, SRC, TEK, TYR |
6.68322 |
[BP] GO:0080134 |
regulation of response to stress
|
ABCB1, ADORA1, APP, CDK6, CYP19A1, DRD2, DUSP3, EGFR, ESR1, F3, FABP4, HSPA1A, IGF1R, MET, MMP2, NUAK1, PPARA, PTPN1, PTPRS, SMAD3, SRC, TEK, XDH |
6.63494 |
[BP] GO:0019748 |
secondary metabolic process
|
AKR1B1, AKR1B10, BCL2, CYP1A1, CYP1A2, CYP1B1, TYR |
6.5761 |
[BP] GO:2000147 |
positive regulation of cell motility
|
APP, BCL2, DRD1, EGFR, F10, F3, IGF1R, INSR, KDR, MET, MMP9, SMAD3, SRC, TEK |
6.53863 |
[BP] GO:0010035 |
response to inorganic substance
|
AKR1B1, ALOX15, APP, BCL2, CA2, CYP1A1, CYP1A2, CYP1B1, DRD2, EGFR, FABP4, KDR, MMP9, SRC |
6.49983 |
[BP] GO:1902533 |
positive regulation of intracellular signal transduction
|
ADORA1, AKR1B1, ALOX15, APP, BCL2, CYP1B1, DRD2, EGFR, F10, F3, GPR35, HSPA1A, INSR, KDR, MET, PTPN1, SRC, TEK, XDH |
6.49665 |
[BP] GO:0051272 |
positive regulation of cellular component movement
|
APP, BCL2, DRD1, EGFR, F10, F3, IGF1R, INSR, KDR, MET, MMP9, SMAD3, SRC, TEK |
6.4251 |
[BP] GO:0009725 |
response to hormone
|
AKR1B1, ALPL, BCL2, CA2, CA9, CSNK2A1, CYP1A2, EGFR, ESR1, ESRRA, FABP3, HSD11B2, INSR, PPARA, SRC, TEK |
6.4251 |
[BP] GO:0044238 |
primary metabolic process
|
ACHE, ADORA1, AKR1B1, AKR1B10, ALOX15, ALPL, AOX1, APP, BCL2, CBR1, CDC25B, CDK6, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP3A4, DRD1, DRD2, DUSP3, EGFR, ESR1, ESR2, ESRRA, ESRRB, F10, F3, FABP3, FABP4, FUT7, GBA2, HSD11B1, HSD11B2, HSD17B1, HSD17B2, HSPA1A, IGF1R, INSR, KDR, MET, MMP1, MMP2, MMP9, NUAK1, PPARA, PTPN1, PTPRS, RORC, SMAD3, SRC, TEK, TNKS, TNKS2, TYR, XDH |
6.42153 |
[BP] GO:0032879 |
regulation of localization
|
ABCB1, ACHE, ADORA1, ADORA3, ALOX15, APP, BCL2, CA2, CA7, CDK6, CSNK2A1, CYP19A1, CYP1B1, DRD1, DRD2, EGFR, F10, F3, GPR35, HSPA1A, IGF1R, INSR, KDR, MET, MMP9, PPARA, PTPN1, SMAD3, SRC, TEK |
6.41023 |
[BP] GO:1902531 |
regulation of intracellular signal transduction
|
ADORA1, AKR1B1, ALOX15, APP, BCL2, CSNK2A1, CYP1B1, DRD2, DUSP3, EGFR, ESR1, F10, F3, GPR35, HSPA1A, IGF1R, INSR, KDR, MET, MMP9, NUAK1, PTPN1, SRC, TEK, XDH |
6.38574 |
[BP] GO:0040017 |
positive regulation of locomotion
|
APP, BCL2, DRD1, EGFR, F10, F3, IGF1R, INSR, KDR, MET, MMP9, SMAD3, SRC, TEK |
6.27485 |
[BP] GO:0048584 |
positive regulation of response to stimulus
|
ADORA1, AKR1B1, ALOX15, APP, BCL2, CSNK2A1, CYP1B1, DRD2, EGFR, ESRRA, F10, F3, FABP4, GPR35, HSPA1A, INSR, KDR, MET, MMP2, MMP9, PTPN1, SMAD3, SRC, TEK, TNKS, TNKS2, XDH |
6.2239 |
[BP] GO:0032501 |
multicellular organismal process
|
ADORA1, AKR1B1, AKR1B10, ALOX15, ALPL, APP, BCL2, CYP19A1, CYP1A2, CYP1B1, DRD1, DRD2, DUSP3, EGFR, ESR1, ESRRB, F10, F3, FABP4, HSD11B2, HSD17B2, IGF1R, INSR, MET, MMP1, MMP2, MMP9, PPARA, RORC, SMAD3, SRC, TEK, TNKS2, TYR |
6.17796 |
[BP] GO:1901615 |
organic hydroxy compound metabolic process
|
AKR1B1, AKR1B10, ALOX15, APP, BCL2, CYP19A1, CYP1A1, CYP1B1, CYP3A4, DRD1, DRD2, GBA2, TYR |
6.14739 |
[BP] GO:0042446 |
hormone biosynthetic process
|
AKR1B1, CYP19A1, CYP3A4, HSD11B1, HSD11B2, HSD17B1, HSD17B2 |
6.14739 |
[BP] GO:0010817 |
regulation of hormone levels
|
ACHE, ADORA1, AKR1B1, CYP19A1, CYP1A1, CYP1B1, CYP3A4, DRD2, EGFR, ESR1, HSD11B1, HSD11B2, HSD17B1, HSD17B2 |
6.07941 |
[BP] GO:0070887 |
cellular response to chemical stimulus
|
AKR1B1, ALOX15, ALPL, APP, BCL2, CDK6, CYP1A1, CYP1A2, CYP1B1, DRD1, EGFR, ESR1, FABP4, HSPA1A, IGF1R, INSR, KDR, MMP2, MMP9, RORC, SMAD3, SRC |
5.88513 |
[BP] GO:0048585 |
negative regulation of response to stimulus
|
ADORA1, ALOX15, BCL2, CDK6, CYP19A1, DRD1, DRD2, DUSP3, EGFR, ESR1, ESR2, HSPA1A, IGF1R, MET, MMP9, PPARA, PTPN1, PTPRS, SMAD3, SRC, TEK, XDH |
5.88513 |
[BP] GO:0034754 |
cellular hormone metabolic process
|
AKR1B1, CYP19A1, CYP1A1, CYP1B1, CYP3A4, ESR1, HSD17B1, HSD17B2 |
5.83342 |
[BP] GO:0050896 |
response to stimulus
|
ABCB1, ACHE, ADORA1, ADORA3, AKR1B1, ALOX15, ALPL, APP, BCL2, CA2, CA6, CA9, CDK6, CSNK2A1, CYP1A1, CYP1A2, CYP1B1, DRD1, DRD2, EGFR, ESR1, ESRRA, F10, F3, FABP3, FABP4, HSD11B2, HSD17B2, HSPA1A, IGF1R, INSR, KDR, MMP2, MMP9, NUAK1, PPARA, PTPN1, RORC, SMAD3, SRC, TEK, TYR |
5.79789 |
[BP] GO:0071704 |
organic substance metabolic process
|
ACHE, ADORA1, AKR1B1, AKR1B10, ALOX15, ALPL, AOX1, APP, BCL2, CBR1, CDC25B, CDK6, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP3A4, DRD1, DRD2, DUSP3, EGFR, ESR1, ESR2, ESRRA, ESRRB, F10, F3, FABP3, FABP4, FUT7, GBA2, HSD11B1, HSD11B2, HSD17B1, HSD17B2, HSPA1A, IGF1R, INSR, KDR, MET, MMP1, MMP2, MMP9, NUAK1, PPARA, PTPN1, PTPRS, RORC, SMAD3, SRC, TEK, TNKS, TNKS2, TYR, XDH |
5.68604 |
[BP] GO:0019220 |
regulation of phosphate metabolic process
|
ADORA1, ALOX15, APP, BCL2, CDC25B, DRD1, DRD2, DUSP3, EGFR, ESRRB, FABP3, FABP4, IGF1R, INSR, KDR, MMP9, NUAK1, PPARA, PTPN1, SMAD3, SRC, TEK, XDH |
5.40423 |
[BP] GO:0009611 |
response to wounding
|
ACHE, ADORA3, ALOX15, BCL2, CYP1A1, DRD2, EGFR, PPARA, SMAD3 |
5.37809 |
[BP] GO:0051174 |
regulation of phosphorus metabolic process
|
ADORA1, ALOX15, APP, BCL2, CDC25B, DRD1, DRD2, DUSP3, EGFR, ESRRB, FABP3, FABP4, IGF1R, INSR, KDR, MMP9, NUAK1, PPARA, PTPN1, SMAD3, SRC, TEK, XDH |
5.35162 |
[BP] GO:0015711 |
organic anion transport
|
ABCB1, CA1, CA12, CA14, CA2, CA4, CA6, CA7, CA9, DRD2, FABP3, PPARA |
5.17147 |
[BP] GO:0006796 |
phosphate-containing compound metabolic process
|
ACHE, ALOX15, ALPL, APP, BCL2, CDC25B, CDK6, CSNK2A1, DRD1, DRD2, DUSP3, EGFR, HSPA1A, IGF1R, INSR, KDR, MET, NUAK1, PTPN1, PTPRS, SRC, TEK, TNKS, XDH |
5.16002 |
[BP] GO:0001666 |
response to hypoxia
|
ADORA1, BCL2, CYP1A1, DRD2, HSD11B2, MMP2, PPARA, SMAD3, SRC, TEK |
5.16002 |
[BP] GO:0071310 |
cellular response to organic substance
|
AKR1B1, ALOX15, ALPL, APP, BCL2, CDK6, CYP1A1, CYP1B1, DRD1, EGFR, ESR1, FABP4, IGF1R, INSR, KDR, MMP2, RORC, SMAD3, SRC |
5.14793 |
[BP] GO:0044255 |
cellular lipid metabolic process
|
ACHE, AKR1B10, ALOX15, CBR1, CSNK2A1, CYP1A1, CYP1A2, CYP1B1, CYP3A4, DRD2, EGFR, FABP3, FABP4, FUT7, GBA2, MET, PPARA |
5.1024 |
[BP] GO:0036293 |
response to decreased oxygen levels
|
ADORA1, BCL2, CYP1A1, DRD2, HSD11B2, MMP2, PPARA, SMAD3, SRC, TEK |
5.06478 |
[BP] GO:0010562 |
positive regulation of phosphorus metabolic process
|
ADORA1, ALOX15, APP, BCL2, CDC25B, DRD1, DRD2, EGFR, ESRRB, FABP3, INSR, KDR, MMP9, PTPN1, SMAD3, SRC, TEK, XDH |
5.06478 |
[BP] GO:0045937 |
positive regulation of phosphate metabolic process
|
ADORA1, ALOX15, APP, BCL2, CDC25B, DRD1, DRD2, EGFR, ESRRB, FABP3, INSR, KDR, MMP9, PTPN1, SMAD3, SRC, TEK, XDH |
5.06478 |
[BP] GO:0017144 |
drug metabolic process
|
ACHE, AKR1B1, AKR1B10, AOX1, CBR1, CYP1A1, CYP1A2, CYP1B1, CYP3A4, DRD1, DRD2, EGFR, HSPA1A |
5.05198 |
[BP] GO:0009966 |
regulation of signal transduction
|
ADORA1, AKR1B1, ALOX15, APP, BCL2, CSNK2A1, CYP1B1, DRD2, DUSP3, EGFR, ESR1, ESR2, F10, F3, GPR35, HSPA1A, IGF1R, INSR, KDR, MET, MMP9, NUAK1, PTPN1, PTPRS, SMAD3, SRC, TEK, TNKS, TNKS2, XDH |
4.99037 |
[BP] GO:0009628 |
response to abiotic stimulus
|
ADORA1, AKR1B1, APP, BCL2, CA2, CYP1A1, DRD1, DRD2, EGFR, HSD11B2, HSPA1A, MMP2, PPARA, SMAD3, SRC, TEK, TYR |
4.89087 |
[BP] GO:0051173 |
positive regulation of nitrogen compound metabolic process
|
ADORA1, ALOX15, APP, BCL2, CDC25B, CSNK2A1, DRD1, DRD2, EGFR, ESR1, ESR2, ESRRA, ESRRB, F3, HSPA1A, IGF1R, INSR, KDR, MET, MMP9, PPARA, PTPN1, RORC, SMAD3, SRC, TEK, TNKS, TNKS2, XDH |
4.87853 |
[BP] GO:1901564 |
organonitrogen compound metabolic process
|
ACHE, AKR1B1, ALPL, AOX1, APP, BCL2, CDC25B, CDK6, CSNK2A1, CYP1A1, CYP1A2, CYP3A4, DRD1, DRD2, DUSP3, EGFR, ESR1, F10, F3, FUT7, GBA2, HSPA1A, IGF1R, INSR, KDR, MET, MMP1, MMP2, MMP9, NUAK1, PPARA, PTPN1, PTPRS, SMAD3, SRC, TEK, TNKS, TNKS2, TYR, XDH |
4.86986 |
[BP] GO:0051896 |
regulation of protein kinase B signaling
|
DRD2, EGFR, F10, F3, INSR, MET, SRC, TEK, XDH |
4.86986 |
[BP] GO:0006793 |
phosphorus metabolic process
|
ACHE, ALOX15, ALPL, APP, BCL2, CDC25B, CDK6, CSNK2A1, DRD1, DRD2, DUSP3, EGFR, HSPA1A, IGF1R, INSR, KDR, MET, NUAK1, PTPN1, PTPRS, SRC, TEK, TNKS, XDH |
4.85107 |
[BP] GO:0010648 |
negative regulation of cell communication
|
ACHE, ADORA1, BCL2, DRD1, DRD2, DUSP3, EGFR, ESR1, ESR2, GPR35, HSPA1A, IGF1R, MET, MMP9, PTPN1, PTPRS, SMAD3, SRC, XDH |
4.84798 |
[BP] GO:0023057 |
negative regulation of signaling
|
ACHE, ADORA1, BCL2, DRD1, DRD2, DUSP3, EGFR, ESR1, ESR2, GPR35, HSPA1A, IGF1R, MET, MMP9, PTPN1, PTPRS, SMAD3, SRC, XDH |
4.83649 |
[BP] GO:0055114 |
oxidation-reduction process
|
AKR1B1, AKR1B10, ALOX15, AOX1, CBR1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP3A4, HSD11B1, HSD11B2, HSD17B1, HSD17B2, TYR, XDH |
4.81675 |
[BP] GO:0070482 |
response to oxygen levels
|
ADORA1, BCL2, CYP1A1, DRD2, HSD11B2, MMP2, PPARA, SMAD3, SRC, TEK |
4.77955 |
[BP] GO:0032844 |
regulation of homeostatic process
|
ADORA1, BCL2, CA2, CA7, CDK6, DRD1, DRD2, EGFR, KDR, SRC, TNKS, TNKS2 |
4.68602 |
[BP] GO:0031325 |
positive regulation of cellular metabolic process
|
ADORA1, ALOX15, APP, BCL2, CDC25B, DRD1, DRD2, EGFR, ESR1, ESR2, ESRRA, ESRRB, F3, FABP3, HSPA1A, IGF1R, INSR, KDR, MET, MMP9, PPARA, PTPN1, RORC, SMAD3, SRC, TEK, TNKS, TNKS2, XDH |
4.57858 |
[BP] GO:0048878 |
chemical homeostasis
|
AKR1B1, APP, BCL2, CA12, CA2, CA7, DRD1, DRD2, EGFR, ESR1, FABP3, FABP4, GPR35, INSR, MET, SMAD3 |
4.53715 |
[BP] GO:0010604 |
positive regulation of macromolecule metabolic process
|
ADORA1, ALOX15, APP, BCL2, CDC25B, CSNK2A1, DRD1, DRD2, EGFR, ESR1, ESR2, ESRRA, ESRRB, F3, HSPA1A, IGF1R, INSR, KDR, MET, MMP9, PPARA, PTPN1, RORC, SMAD3, SRC, TEK, TNKS, TNKS2, XDH |
4.53715 |
[BP] GO:0042325 |
regulation of phosphorylation
|
ADORA1, ALOX15, APP, BCL2, CDC25B, DRD1, DRD2, DUSP3, EGFR, ESRRB, FABP4, IGF1R, INSR, KDR, MMP9, PPARA, PTPN1, SRC, TEK, XDH |
4.52848 |
[BP] GO:0001503 |
ossification
|
ALOX15, ALPL, BCL2, EGFR, MMP2, MMP9, TEK |
4.48834 |
[BP] GO:0010038 |
response to metal ion
|
ALOX15, APP, BCL2, CA2, CYP1A1, CYP1A2, DRD2, EGFR, FABP4, MMP9 |
4.45347 |
[BP] GO:0009893 |
positive regulation of metabolic process
|
ADORA1, ALOX15, APP, BCL2, CDC25B, CSNK2A1, DRD1, DRD2, EGFR, ESR1, ESR2, ESRRA, ESRRB, F3, FABP3, HSPA1A, IGF1R, INSR, KDR, MET, MMP9, PPARA, PTPN1, RORC, SMAD3, SRC, TEK, TNKS, TNKS2, XDH |
4.45347 |
[BP] GO:0032847 |
regulation of cellular pH reduction
|
BCL2, CA2, CA7 |
4.45347 |
[BP] GO:0048523 |
negative regulation of cellular process
|
ACHE, ADORA1, ADORA3, AKR1B1, APP, BCL2, CDK6, CSNK2A1, CYP19A1, CYP1B1, DRD1, DRD2, DUSP3, EGFR, ESR1, ESR2, ESRRA, ESRRB, FABP3, FABP4, GPR35, HSPA1A, IGF1R, KDR, MET, MMP9, PPARA, PTPN1, PTPRS, RORC, SMAD3, SRC, TEK, TNKS, TNKS2, XDH |
4.41774 |
[BP] GO:0042493 |
response to drug
|
ABCB1, AKR1B1, BCL2, CA9, CDK6, CYP1A1, CYP1B1, DRD1, DRD2, EGFR, FABP3, HSD11B2, KDR, SRC |
4.34017 |
[BP] GO:0050806 |
positive regulation of synaptic transmission
|
ADORA1, APP, CA2, CA7, DRD1, DRD2, EGFR |
4.34017 |
[BP] GO:0065009 |
regulation of molecular function
|
ABCB1, ADORA1, ADORA3, APP, BCL2, CDC25B, CSNK2A1, CYP1B1, DRD1, DRD2, DUSP3, EGFR, ESR1, ESR2, F3, FABP4, GPR35, HSPA1A, IGF1R, INSR, MET, MMP9, NUAK1, PPARA, PTPN1, SMAD3, SRC, TEK, TNKS, XDH |
4.2854 |
[BP] GO:0006694 |
steroid biosynthetic process
|
AKR1B1, CYP19A1, CYP3A4, HSD11B1, HSD11B2, HSD17B1, HSD17B2 |
4.23982 |
[BP] GO:0010243 |
response to organonitrogen compound
|
AKR1B1, APP, DRD1, DRD2, EGFR, FABP3, HSD11B2, IGF1R, INSR, MMP2, PPARA, SRC, TEK, TYR |
4.19085 |
[BP] GO:0008284 |
positive regulation of cell proliferation
|
AKR1B1, BCL2, CDC25B, CDK6, CSNK2A1, DRD2, EGFR, ESR1, F3, IGF1R, INSR, KDR, MMP2, MMP9, TEK |
4.18469 |
[BP] GO:0043401 |
steroid hormone mediated signaling pathway
|
ESR1, ESR2, ESRRA, ESRRB, PPARA, RORC, SRC |
4.16255 |
[BP] GO:0051716 |
cellular response to stimulus
|
AKR1B1, ALOX15, ALPL, APP, BCL2, CA2, CA9, CDK6, CYP1A1, CYP1A2, CYP1B1, DRD1, EGFR, ESR1, FABP4, HSPA1A, IGF1R, INSR, KDR, MMP2, MMP9, NUAK1, PTPN1, RORC, SMAD3, SRC |
4.16052 |
[BP] GO:0006820 |
anion transport
|
ABCB1, CA1, CA12, CA14, CA2, CA4, CA6, CA7, CA9, DRD2, FABP3, PPARA |
4.14323 |
[BP] GO:0016042 |
lipid catabolic process
|
ADORA1, AKR1B10, CYP19A1, CYP1A2, CYP1B1, CYP3A4, FABP3, FABP4, GBA2 |
4.10652 |
[BP] GO:0051130 |
positive regulation of cellular component organization
|
ALOX15, APP, BCL2, DRD2, ESR1, HSPA1A, IGF1R, INSR, KDR, MET, MMP1, MMP9, SMAD3, SRC, TEK, TNKS, TNKS2 |
4.0928 |
[BP] GO:0050790 |
regulation of catalytic activity
|
ADORA1, ADORA3, APP, BCL2, CDC25B, CSNK2A1, DRD1, DRD2, DUSP3, EGFR, ESR1, F3, FABP4, HSPA1A, IGF1R, INSR, MMP9, NUAK1, PTPN1, SMAD3, SRC, TEK, TNKS, XDH |
4.07449 |
[BP] GO:0032101 |
regulation of response to external stimulus
|
ADORA1, CYP19A1, DRD1, DRD2, EGFR, ESR1, F3, FABP4, KDR, MET, PPARA, PTPRS, SMAD3, TEK |
4.06861 |
[BP] GO:0070372 |
regulation of ERK1 and ERK2 cascade
|
ALOX15, APP, DRD2, DUSP3, EGFR, KDR, PTPN1, SRC, TEK |
4.06734 |
[BP] GO:0031347 |
regulation of defense response
|
ADORA1, CYP19A1, DRD2, EGFR, ESR1, FABP4, HSPA1A, MMP2, PPARA, PTPN1, PTPRS, SMAD3, SRC, TEK |
4.05137 |
[BP] GO:0038083 |
peptidyl-tyrosine autophosphorylation
|
EGFR, IGF1R, INSR, KDR, SRC |
3.95837 |
[BP] GO:2000021 |
regulation of ion homeostasis
|
ADORA1, BCL2, CA2, CA7, DRD1, DRD2, KDR, SRC |
3.93897 |
[BP] GO:0006468 |
protein phosphorylation
|
APP, BCL2, CDC25B, CDK6, CSNK2A1, DRD1, EGFR, IGF1R, INSR, KDR, MET, NUAK1, SRC, TEK, TNKS |
3.9201 |
[BP] GO:0042592 |
homeostatic process
|
ADORA1, AKR1B1, APP, BCL2, CA12, CA2, CA7, DRD1, DRD2, EGFR, ESR1, FABP3, FABP4, GPR35, INSR, MET, SMAD3, SRC |
3.91096 |
[BP] GO:1901698 |
response to nitrogen compound
|
AKR1B1, APP, DRD1, DRD2, EGFR, FABP3, HSD11B2, IGF1R, INSR, MMP2, PPARA, SRC, TEK, TYR |
3.85412 |
[BP] GO:0060548 |
negative regulation of cell death
|
ADORA1, AKR1B1, BCL2, CSNK2A1, EGFR, HSPA1A, IGF1R, KDR, MET, MMP9, PPARA, PTPN1, SMAD3, SRC, TEK |
3.84683 |
[BP] GO:0001932 |
regulation of protein phosphorylation
|
ADORA1, ALOX15, APP, BCL2, CDC25B, DRD1, DRD2, DUSP3, EGFR, FABP4, IGF1R, INSR, KDR, MMP9, PTPN1, SRC, TEK, XDH |
3.83686 |
[BP] GO:0048519 |
negative regulation of biological process
|
ACHE, ADORA1, ADORA3, AKR1B1, ALOX15, APP, BCL2, CDK6, CSNK2A1, CYP19A1, CYP1B1, DRD1, DRD2, DUSP3, EGFR, ESR1, ESR2, ESRRA, ESRRB, FABP3, FABP4, GPR35, HSPA1A, IGF1R, KDR, MET, MMP9, PPARA, PTPN1, PTPRS, RORC, SMAD3, SRC, TEK, TNKS, TNKS2, XDH |
3.78573 |
[BP] GO:0051897 |
positive regulation of protein kinase B signaling
|
EGFR, F10, F3, INSR, MET, SRC, TEK |
3.7723 |
[BP] GO:0043408 |
regulation of MAPK cascade
|
ADORA1, ALOX15, APP, DRD2, DUSP3, EGFR, IGF1R, INSR, KDR, PTPN1, SRC, TEK, XDH |
3.74934 |
[BP] GO:0019369 |
arachidonic acid metabolic process
|
ALOX15, CBR1, CYP1A1, CYP1A2, CYP1B1 |
3.69191 |
[BP] GO:0042327 |
positive regulation of phosphorylation
|
ADORA1, ALOX15, APP, BCL2, CDC25B, DRD2, EGFR, ESRRB, INSR, KDR, MMP9, PTPN1, SRC, TEK, XDH |
3.66033 |
[BP] GO:0008210 |
estrogen metabolic process
|
CYP19A1, CYP1B1, HSD17B1, HSD17B2 |
3.66033 |
[BP] GO:0010638 |
positive regulation of organelle organization
|
ALOX15, BCL2, HSPA1A, INSR, KDR, MET, MMP9, SMAD3, SRC, TEK, TNKS, TNKS2 |
3.66033 |
[BP] GO:0044093 |
positive regulation of molecular function
|
ABCB1, ADORA1, APP, BCL2, CDC25B, DRD2, EGFR, ESR1, ESR2, F3, HSPA1A, INSR, MET, MMP9, PTPN1, SMAD3, SRC, TEK, TNKS, XDH |
3.66011 |
[BP] GO:0048869 |
cellular developmental process
|
ACHE, ALPL, APP, BCL2, CBR1, CDC25B, CDK6, CYP1A1, DRD1, DRD2, EGFR, ESR1, ESRRB, FABP4, FUT7, GBA2, KDR, MET, MMP2, MMP9, PTPRS, RORC, SMAD3, SRC, TEK |
3.641 |
[BP] GO:0043410 |
positive regulation of MAPK cascade
|
ADORA1, ALOX15, APP, DRD2, EGFR, INSR, KDR, PTPN1, SRC, TEK, XDH |
3.62569 |
[BP] GO:0043069 |
negative regulation of programmed cell death
|
ADORA1, AKR1B1, BCL2, CSNK2A1, EGFR, HSPA1A, IGF1R, KDR, MET, MMP9, PTPN1, SMAD3, SRC, TEK |
3.60701 |
[BP] GO:0001952 |
regulation of cell-matrix adhesion
|
BCL2, CDK6, KDR, SMAD3, SRC, TEK |
3.60573 |
[BP] GO:1902532 |
negative regulation of intracellular signal transduction
|
BCL2, DRD2, DUSP3, ESR1, HSPA1A, IGF1R, MET, MMP9, PTPN1, SRC, XDH |
3.58843 |
[BP] GO:0031399 |
regulation of protein modification process
|
ADORA1, ALOX15, APP, BCL2, CDC25B, DRD1, DRD2, DUSP3, EGFR, FABP4, HSPA1A, IGF1R, INSR, KDR, MMP9, NUAK1, PTPN1, SRC, TEK, XDH |
3.58098 |
[BP] GO:1901701 |
cellular response to oxygen-containing compound
|
AKR1B1, APP, CDK6, CYP1B1, DRD1, EGFR, ESR1, IGF1R, INSR, MMP2, MMP9, RORC, SRC |
3.55302 |
[BP] GO:0009755 |
hormone-mediated signaling pathway
|
ESR1, ESR2, ESRRA, ESRRB, PPARA, RORC, SRC |
3.54412 |
[BP] GO:0051247 |
positive regulation of protein metabolic process
|
ADORA1, ALOX15, APP, BCL2, CDC25B, CSNK2A1, DRD2, EGFR, ESR1, F3, HSPA1A, INSR, KDR, MMP9, PTPN1, SMAD3, SRC, TEK, XDH |
3.53905 |
[BP] GO:0006721 |
terpenoid metabolic process
|
AKR1B10, CYP1A1, CYP1A2, CYP1B1, CYP3A4, EGFR |
3.52912 |
[BP] GO:0044092 |
negative regulation of molecular function
|
ADORA3, APP, CSNK2A1, CYP1B1, DRD2, DUSP3, ESR1, FABP4, GPR35, IGF1R, MET, MMP9, PPARA, PTPN1, SRC, TNKS |
3.50993 |
[BP] GO:0010941 |
regulation of cell death
|
ADORA1, AKR1B1, BCL2, CSNK2A1, CYP1B1, EGFR, ESR1, F3, HSPA1A, IGF1R, KDR, MET, MMP9, PPARA, PTPN1, SMAD3, SRC, TEK, XDH |
3.47119 |
[BP] GO:0007166 |
cell surface receptor signaling pathway
|
ADORA1, ADORA3, APP, BCL2, CA1, CSNK2A1, DRD2, EGFR, F3, GPR35, IGF1R, INSR, KDR, MET, MMP2, MMP9, PTPN1, SMAD3, SRC, TEK, TNKS, TNKS2 |
3.43548 |
[BP] GO:0030522 |
intracellular receptor signaling pathway
|
ESR1, ESR2, ESRRA, ESRRB, PPARA, RORC, SRC |
3.4286 |
[BP] GO:0009056 |
catabolic process
|
ACHE, ADORA1, AKR1B10, AOX1, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP3A4, FABP3, FABP4, FUT7, GBA2, HSPA1A, MMP1, MMP2, MMP9, SRC, XDH |
3.37467 |
[BP] GO:0022414 |
reproductive process
|
AKR1B1, ALPL, APP, BCL2, CDC25B, CYP19A1, CYP1A1, DRD1, EGFR, ESR1, ESRRB, HSD11B2, HSD17B2, INSR, MMP2, MMP9, SRC |
3.34775 |
[BP] GO:0008610 |
lipid biosynthetic process
|
ACHE, AKR1B1, ALOX15, CSNK2A1, CYP19A1, CYP1A1, CYP3A4, HSD11B1, HSD11B2, HSD17B1, HSD17B2 |
3.34775 |
[BP] GO:0050801 |
ion homeostasis
|
APP, BCL2, CA12, CA2, CA7, DRD1, DRD2, EGFR, ESR1, FABP3, GPR35, SMAD3 |
3.34775 |
[BP] GO:1901652 |
response to peptide
|
AKR1B1, APP, FABP3, HSD11B2, IGF1R, INSR, PPARA, SRC, TEK |
3.33467 |
[BP] GO:0043067 |
regulation of programmed cell death
|
ADORA1, AKR1B1, BCL2, CSNK2A1, CYP1B1, EGFR, ESR1, F3, HSPA1A, IGF1R, KDR, MET, MMP9, PTPN1, SMAD3, SRC, TEK, XDH |
3.33467 |
[BP] GO:0071407 |
cellular response to organic cyclic compound
|
ALPL, APP, CYP1A1, CYP1B1, DRD1, EGFR, ESR1, RORC, SRC |
3.31718 |
[BP] GO:0051049 |
regulation of transport
|
ABCB1, ACHE, ADORA1, ALOX15, APP, BCL2, CA2, CA7, CYP19A1, DRD1, DRD2, EGFR, GPR35, HSPA1A, INSR, MMP9, PPARA, PTPN1, SMAD3, SRC |
3.31718 |
[BP] GO:0032270 |
positive regulation of cellular protein metabolic process
|
ADORA1, ALOX15, APP, BCL2, CDC25B, DRD2, EGFR, ESR1, F3, HSPA1A, INSR, KDR, MMP9, PTPN1, SMAD3, SRC, TEK, XDH |
3.29833 |
[BP] GO:0018108 |
peptidyl-tyrosine phosphorylation
|
EGFR, IGF1R, INSR, KDR, MET, SRC, TEK |
3.29021 |
[BP] GO:0010810 |
regulation of cell-substrate adhesion
|
ALOX15, BCL2, CDK6, KDR, SMAD3, SRC, TEK |
3.26209 |
[BP] GO:0001934 |
positive regulation of protein phosphorylation
|
ADORA1, ALOX15, APP, BCL2, CDC25B, DRD2, EGFR, INSR, KDR, MMP9, PTPN1, SRC, TEK, XDH |
3.25234 |
[BP] GO:0018212 |
peptidyl-tyrosine modification
|
EGFR, IGF1R, INSR, KDR, MET, SRC, TEK |
3.25189 |
[BP] GO:0032228 |
regulation of synaptic transmission, GABAergic
|
ADORA1, CA2, CA7, DRD2 |
3.23894 |
[BP] GO:2001225 |
regulation of chloride transport
|
ABCB1, CA2, CA7 |
3.22537 |
[BP] GO:0097267 |
omega-hydroxylase P450 pathway
|
CYP1A1, CYP1A2, CYP1B1 |
3.22537 |
[BP] GO:0045935 |
positive regulation of nucleobase-containing compound metabolic process
|
APP, DRD1, DRD2, EGFR, ESR1, ESR2, ESRRA, ESRRB, HSPA1A, IGF1R, INSR, MET, PPARA, PTPN1, RORC, SMAD3, SRC, TNKS, TNKS2 |
3.22406 |
[BP] GO:0006720 |
isoprenoid metabolic process
|
AKR1B10, CYP1A1, CYP1A2, CYP1B1, CYP3A4, EGFR |
3.2118 |
[BP] GO:0010907 |
None
|
ESRRB, INSR, PPARA, SRC |
3.19845 |
[BP] GO:0046777 |
protein autophosphorylation
|
CSNK2A1, EGFR, IGF1R, INSR, KDR, SRC, TEK |
3.16976 |
[BP] GO:0070374 |
positive regulation of ERK1 and ERK2 cascade
|
ALOX15, APP, DRD2, EGFR, KDR, SRC, TEK |
3.15995 |
[BP] GO:0032102 |
negative regulation of response to external stimulus
|
ADORA1, CYP19A1, DRD1, DRD2, PPARA, PTPRS, SMAD3, TEK |
3.15697 |
[BP] GO:0002009 |
morphogenesis of an epithelium
|
BCL2, CA2, CA9, EGFR, ESR1, MET, SMAD3, SRC |
3.12527 |
[BP] GO:0051239 |
regulation of multicellular organismal process
|
ADORA1, ADORA3, APP, BCL2, CA2, CDK6, CYP1B1, DRD2, EGFR, ESR1, ESRRA, ESRRB, F3, GPR35, HSPA1A, INSR, KDR, MET, MMP9, PTPRS, SMAD3, SRC, TEK, TNKS2, XDH |
3.10741 |
[BP] GO:0048511 |
rhythmic process
|
BCL2, CSNK2A1, DRD2, EGFR, ESR1, PPARA, RORC, SRC |
3.10741 |
[BP] GO:0043066 |
negative regulation of apoptotic process
|
ADORA1, AKR1B1, BCL2, CSNK2A1, EGFR, HSPA1A, IGF1R, KDR, MMP9, PTPN1, SMAD3, SRC, TEK |
3.05983 |
[BP] GO:0032268 |
regulation of cellular protein metabolic process
|
ADORA1, ALOX15, APP, BCL2, CDC25B, CSNK2A1, DRD1, DRD2, DUSP3, EGFR, ESR1, F3, FABP4, HSPA1A, IGF1R, INSR, KDR, MMP9, NUAK1, PTPN1, SMAD3, SRC, TEK, XDH |
3.05313 |
[BP] GO:0018958 |
None
|
AKR1B1, BCL2, DRD1, DRD2, TYR |
3.04367 |
[BP] GO:0007165 |
signal transduction
|
ADORA1, ADORA3, AKR1B1, APP, BCL2, CA1, CA2, CDK6, CSNK2A1, CYP1B1, DRD1, DRD2, EGFR, ESR1, ESR2, ESRRA, ESRRB, F3, GPR35, IGF1R, INSR, KDR, MET, MMP2, MMP9, NUAK1, PPARA, PTPN1, RORC, SMAD3, SRC, TEK, TNKS, TNKS2 |
3.01863 |
[BP] GO:0051128 |
regulation of cellular component organization
|
ALOX15, APP, BCL2, CSNK2A1, DRD2, EGFR, ESR1, ESR2, HSPA1A, IGF1R, INSR, KDR, MET, MMP1, MMP9, PTPN1, PTPRS, SMAD3, SRC, TEK, TNKS, TNKS2 |
3.01129 |
[BP] GO:0016310 |
phosphorylation
|
APP, BCL2, CDC25B, CDK6, CSNK2A1, DRD1, EGFR, IGF1R, INSR, KDR, MET, NUAK1, SRC, TEK, TNKS |
2.99836 |
[BP] GO:0007169 |
transmembrane receptor protein tyrosine kinase signaling pathway
|
EGFR, IGF1R, INSR, KDR, MET, MMP2, MMP9, PTPN1, SRC, TEK |
2.99798 |
[BP] GO:0009891 |
positive regulation of biosynthetic process
|
APP, DRD1, DRD2, EGFR, ESR1, ESR2, ESRRA, ESRRB, FABP3, IGF1R, INSR, KDR, MET, PPARA, RORC, SMAD3, SRC, TNKS, TNKS2 |
2.95766 |
[BP] GO:0050804 |
modulation of chemical synaptic transmission
|
ACHE, ADORA1, APP, CA2, CA7, DRD1, DRD2, EGFR |
2.95003 |
[BP] GO:0099177 |
regulation of trans-synaptic signaling
|
ACHE, ADORA1, APP, CA2, CA7, DRD1, DRD2, EGFR |
2.95003 |
[BP] GO:0009636 |
response to toxic substance
|
AKR1B1, ALPL, BCL2, CYP1A1, CYP1B1, DRD1, DRD2, KDR, SRC |
2.9221 |
[BP] GO:0032845 |
None
|
ADORA1, BCL2, DRD2, SRC, TNKS, TNKS2 |
2.90827 |
[BP] GO:0006703 |
estrogen biosynthetic process
|
CYP19A1, HSD17B1, HSD17B2 |
2.90796 |
[BP] GO:0009115 |
None
|
AOX1, XDH |
2.89496 |
[BP] GO:0006950 |
response to stress
|
ACHE, ADORA1, ADORA3, AKR1B1, ALOX15, APP, BCL2, CA2, CA9, CYP1A1, CYP1A2, CYP1B1, DRD1, DRD2, EGFR, HSD11B2, HSPA1A, MMP2, MMP9, NUAK1, PPARA, PTPN1, SMAD3, SRC, TEK |
2.89496 |
[BP] GO:0009968 |
negative regulation of signal transduction
|
BCL2, DRD2, DUSP3, EGFR, ESR1, ESR2, HSPA1A, IGF1R, MET, MMP9, PTPN1, PTPRS, SMAD3, SRC, XDH |
2.8844 |
[BP] GO:0042981 |
regulation of apoptotic process
|
ADORA1, AKR1B1, BCL2, CSNK2A1, CYP1B1, EGFR, ESR1, F3, HSPA1A, IGF1R, KDR, MMP9, PTPN1, SMAD3, SRC, TEK, XDH |
2.86401 |
[BP] GO:0071248 |
cellular response to metal ion
|
ALOX15, CYP1A1, CYP1A2, EGFR, FABP4, MMP9 |
2.85915 |
[BP] GO:0098771 |
inorganic ion homeostasis
|
APP, BCL2, CA12, CA2, CA7, DRD1, DRD2, EGFR, ESR1, GPR35, SMAD3 |
2.84803 |
[BP] GO:0032846 |
positive regulation of homeostatic process
|
CA2, CA7, DRD1, DRD2, EGFR, TNKS, TNKS2 |
2.83417 |
[BP] GO:0060065 |
uterus development
|
CYP19A1, ESR1, SRC |
2.82702 |
[BP] GO:0080135 |
regulation of cellular response to stress
|
APP, CDK6, DUSP3, EGFR, HSPA1A, IGF1R, MET, NUAK1, PTPN1, PTPRS, XDH |
2.81032 |
[BP] GO:0002682 |
regulation of immune system process
|
ADORA1, ALOX15, APP, BCL2, CA2, CDK6, CYP19A1, DRD2, DUSP3, ESR1, ESRRA, HSPA1A, MMP2, PTPN1, PTPRS, SMAD3, SRC |
2.79037 |
[BP] GO:0040008 |
regulation of growth
|
APP, BCL2, CSNK2A1, DRD2, EGFR, ESR2, HSPA1A, INSR, PTPRS, SMAD3, TNKS2 |
2.78956 |
[BP] GO:0007346 |
regulation of mitotic cell cycle
|
APP, BCL2, CDC25B, CDK6, CYP1A1, DUSP3, EGFR, HSPA1A, INSR, SMAD3, TNKS |
2.75868 |
[BP] GO:0001954 |
positive regulation of cell-matrix adhesion
|
CDK6, KDR, SMAD3, TEK |
2.73687 |
[BP] GO:0050793 |
regulation of developmental process
|
APP, BCL2, CA2, CDK6, CYP1B1, DRD2, EGFR, ESR1, ESRRA, ESRRB, F3, INSR, KDR, NUAK1, PPARA, PTPRS, RORC, SMAD3, SRC, TEK, TNKS2, XDH |
2.7275 |
[BP] GO:0051701 |
interaction with host
|
EGFR, HSPA1A, INSR, MET, SMAD3, SRC |
2.72359 |
[BP] GO:0030155 |
regulation of cell adhesion
|
ALOX15, BCL2, CDK6, CYP1B1, DUSP3, KDR, NUAK1, PPARA, SMAD3, SRC, TEK |
2.70794 |
[BP] GO:0006367 |
transcription initiation from RNA polymerase II promoter
|
ESR1, ESR2, ESRRA, ESRRB, PPARA, RORC |
2.69728 |
[BP] GO:2001243 |
negative regulation of intrinsic apoptotic signaling pathway
|
BCL2, HSPA1A, MMP9, PTPN1, SRC |
2.69728 |
[BP] GO:0007167 |
enzyme linked receptor protein signaling pathway
|
EGFR, IGF1R, INSR, KDR, MET, MMP2, MMP9, PTPN1, SMAD3, SRC, TEK |
2.68384 |
[BP] GO:0010906 |
None
|
ESRRB, INSR, PPARA, RORC, SRC |
2.68088 |
[BP] GO:0003014 |
None
|
ADORA1, AKR1B1, BCL2, DRD2, HSD11B2 |
2.68088 |
[BP] GO:0048732 |
gland development
|
BCL2, CSNK2A1, CYP19A1, EGFR, INSR, SMAD3, TYR |
2.67765 |
[BP] GO:0033559 |
unsaturated fatty acid metabolic process
|
ALOX15, CBR1, CYP1A1, CYP1A2, CYP1B1 |
2.6628 |
[BP] GO:0043085 |
positive regulation of catalytic activity
|
ADORA1, APP, BCL2, CDC25B, DRD2, EGFR, ESR1, F3, HSPA1A, INSR, PTPN1, SMAD3, SRC, TEK, TNKS, XDH |
2.61483 |
[BP] GO:0006979 |
response to oxidative stress
|
AKR1B1, APP, BCL2, CYP1B1, EGFR, HSPA1A, MMP9, SRC |
2.61483 |
[BP] GO:0051098 |
regulation of binding
|
APP, BCL2, MET, MMP9, PPARA, SMAD3, SRC, TNKS |
2.61483 |
[BP] GO:0001676 |
long-chain fatty acid metabolic process
|
ALOX15, CBR1, CYP1A1, CYP1A2, CYP1B1 |
2.6098 |
[BP] GO:0051050 |
positive regulation of transport
|
ABCB1, ACHE, ADORA1, APP, BCL2, CA2, CYP19A1, DRD1, DRD2, EGFR, INSR, SMAD3, SRC |
2.60719 |
[BP] GO:2000377 |
regulation of reactive oxygen species metabolic process
|
BCL2, CYP1B1, EGFR, INSR, SMAD3, XDH |
2.58831 |
[BP] GO:0072593 |
reactive oxygen species metabolic process
|
BCL2, CYP1A1, CYP1A2, CYP1B1, EGFR |
2.57368 |
[BP] GO:0031348 |
negative regulation of defense response
|
ADORA1, CYP19A1, DRD2, PPARA, SMAD3, TEK |
2.56315 |
[BP] GO:0031328 |
positive regulation of cellular biosynthetic process
|
APP, DRD1, DRD2, EGFR, ESR1, ESR2, ESRRA, ESRRB, FABP3, IGF1R, INSR, MET, PPARA, RORC, SMAD3, SRC, TNKS, TNKS2 |
2.56098 |
[BP] GO:0001505 |
regulation of neurotransmitter levels
|
ACHE, CYP1B1, DRD1, DRD2, EGFR, INSR, SMAD3 |
2.55582 |
[BP] GO:0071241 |
cellular response to inorganic substance
|
ALOX15, CYP1A1, CYP1A2, EGFR, FABP4, MMP9 |
2.55423 |
[BP] GO:0008285 |
negative regulation of cell proliferation
|
ADORA1, ADORA3, APP, BCL2, CDK6, CYP1B1, DRD2, FABP3, HSPA1A, SMAD3, XDH |
2.55062 |
[BP] GO:0006690 |
icosanoid metabolic process
|
ALOX15, CBR1, CYP1A1, CYP1A2, CYP1B1 |
2.54776 |
[BP] GO:0016137 |
None
|
AKR1B1, AKR1B10, GBA2 |
2.54776 |
[BP] GO:0010676 |
None
|
ESRRB, INSR, PPARA, SRC |
2.54038 |
[BP] GO:0000302 |
response to reactive oxygen species
|
AKR1B1, BCL2, CYP1B1, EGFR, MMP9, SRC |
2.53819 |
[BP] GO:0048729 |
tissue morphogenesis
|
BCL2, CA2, CA9, EGFR, ESR1, MET, SMAD3, SRC |
2.53673 |
[BP] GO:0010811 |
positive regulation of cell-substrate adhesion
|
ALOX15, CDK6, KDR, SMAD3, TEK |
2.51922 |
[BP] GO:0046110 |
None
|
AOX1, XDH |
2.51578 |
[BP] GO:0032849 |
positive regulation of cellular pH reduction
|
CA2, CA7 |
2.51578 |
[BP] GO:0043549 |
regulation of kinase activity
|
ADORA1, APP, CDC25B, DRD2, DUSP3, EGFR, FABP4, IGF1R, INSR, PTPN1, SRC, TEK |
2.51178 |
[BP] GO:0051900 |
regulation of mitochondrial depolarization
|
BCL2, KDR, SRC |
2.4953 |
[BP] GO:0051893 |
regulation of focal adhesion assembly
|
KDR, SMAD3, SRC, TEK |
2.4953 |
[BP] GO:0090109 |
regulation of cell-substrate junction assembly
|
KDR, SMAD3, SRC, TEK |
2.4953 |
[BP] GO:0034614 |
cellular response to reactive oxygen species
|
AKR1B1, CYP1B1, EGFR, MMP9, SRC |
2.4951 |
[BP] GO:0010564 |
regulation of cell cycle process
|
APP, BCL2, CDC25B, CDK6, CSNK2A1, CYP1A1, DRD2, EGFR, HSPA1A, INSR, TNKS |
2.4936 |
[BP] GO:0019538 |
protein metabolic process
|
ACHE, ALPL, APP, BCL2, CDC25B, CDK6, CSNK2A1, DRD1, DUSP3, EGFR, ESR1, F10, F3, FUT7, IGF1R, INSR, KDR, MET, MMP1, MMP2, MMP9, NUAK1, PPARA, PTPN1, PTPRS, SMAD3, SRC, TEK, TNKS, TNKS2 |
2.46785 |
[BP] GO:0097164 |
None
|
ACHE, AKR1B1, AKR1B10, CSNK2A1, DRD1, DRD2 |
2.45706 |
[BP] GO:0003006 |
developmental process involved in reproduction
|
ALPL, BCL2, CDC25B, CYP19A1, EGFR, ESR1, ESRRB, HSD17B2, INSR, SRC |
2.44787 |
[BP] GO:0051246 |
regulation of protein metabolic process
|
ADORA1, ALOX15, APP, BCL2, CDC25B, CSNK2A1, DRD1, DRD2, DUSP3, EGFR, ESR1, F3, FABP4, HSPA1A, IGF1R, INSR, KDR, MMP9, NUAK1, PTPN1, SMAD3, SRC, TEK, XDH |
2.44108 |
[BP] GO:0045787 |
positive regulation of cell cycle
|
APP, CDC25B, CYP1A1, DRD2, DUSP3, EGFR, INSR, SRC |
2.43414 |
[BP] GO:0009892 |
negative regulation of metabolic process
|
ADORA1, APP, BCL2, CSNK2A1, DRD2, DUSP3, EGFR, ESR1, ESR2, ESRRA, FABP4, HSPA1A, IGF1R, KDR, MET, MMP9, PPARA, PTPN1, RORC, SMAD3, SRC, TNKS, TNKS2, XDH |
2.43402 |
[BP] GO:0051726 |
regulation of cell cycle
|
APP, BCL2, CDC25B, CDK6, CSNK2A1, CYP1A1, DRD2, DUSP3, EGFR, HSPA1A, INSR, SMAD3, SRC, TNKS |
2.43365 |
[BP] GO:0051338 |
regulation of transferase activity
|
ADORA1, APP, CDC25B, DRD2, DUSP3, EGFR, FABP4, IGF1R, INSR, PTPN1, SRC, TEK, TNKS |
2.43352 |
[BP] GO:0010557 |
positive regulation of macromolecule biosynthetic process
|
APP, DRD2, EGFR, ESR1, ESR2, ESRRA, ESRRB, IGF1R, INSR, KDR, MET, PPARA, RORC, SMAD3, SRC, TNKS, TNKS2 |
2.43352 |
[BP] GO:1903391 |
regulation of adherens junction organization
|
KDR, SMAD3, SRC, TEK |
2.42608 |
[BP] GO:0044089 |
positive regulation of cellular component biogenesis
|
ALOX15, ESR1, HSPA1A, KDR, MET, MMP1, SMAD3, SRC, TEK |
2.41751 |
[BP] GO:0043269 |
regulation of ion transport
|
ABCB1, ADORA1, APP, BCL2, CA2, CA7, DRD1, DRD2, GPR35, MMP9 |
2.41077 |
[BP] GO:0006805 |
xenobiotic metabolic process
|
CYP1A1, CYP1A2, CYP1B1, CYP3A4, RORC |
2.40939 |
[BP] GO:0018193 |
peptidyl-amino acid modification
|
BCL2, CSNK2A1, DRD1, EGFR, F10, IGF1R, INSR, KDR, MET, SRC, TEK, TNKS |
2.40718 |
[BP] GO:0050728 |
negative regulation of inflammatory response
|
ADORA1, CYP19A1, PPARA, SMAD3, TEK |
2.39688 |
[BP] GO:0019373 |
epoxygenase P450 pathway
|
CYP1A1, CYP1A2, CYP1B1 |
2.39688 |
[BP] GO:0051966 |
regulation of synaptic transmission, glutamatergic
|
ADORA1, DRD1, DRD2, EGFR |
2.38059 |
[BP] GO:0035690 |
cellular response to drug
|
AKR1B1, CDK6, CYP1B1, DRD1, EGFR, KDR, SRC |
2.35178 |
[BP] GO:0048871 |
multicellular organismal homeostasis
|
ADORA1, AKR1B1, DRD1, DRD2, MET |
2.34995 |
[BP] GO:0009987 |
cellular process
|
ABCB1, ACHE, ADORA1, ADORA3, AKR1B1, AKR1B10, ALOX15, ALPL, AOX1, APP, BCL2, CA1, CA12, CA2, CA4, CA6, CA7, CA9, CBR1, CDC25B, CDK6, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP3A4, DRD1, DRD2, DUSP3, EGFR, ESR1, ESR2, ESRRA, ESRRB, F10, F3, FABP3, FABP4, FUT7, GBA2, GPR35, HSD17B1, HSD17B2, HSPA1A, IGF1R, INSR, KDR, MET, MMP1, MMP2, MMP9, NUAK1, PPARA, PTPN1, PTPRS, RORC, SMAD3, SRC, TEK, TNKS, TNKS2, TUBB3, TYR, XDH |
2.34326 |
[BP] GO:0030520 |
intracellular estrogen receptor signaling pathway
|
ESR1, ESR2, SRC |
2.34326 |
[BP] GO:0048468 |
cell development
|
ACHE, APP, BCL2, CDK6, DRD1, ESR1, GBA2, PTPRS, SMAD3, SRC |
2.34195 |
[BP] GO:0034599 |
cellular response to oxidative stress
|
AKR1B1, CYP1B1, EGFR, HSPA1A, MMP9, SRC |
2.34195 |
[BP] GO:0019222 |
regulation of metabolic process
|
ACHE, ADORA1, ADORA3, ALOX15, APP, BCL2, CA9, CDC25B, CDK6, CSNK2A1, CYP1A1, CYP1A2, CYP1B1, DRD1, DRD2, DUSP3, EGFR, ESR1, ESR2, ESRRA, ESRRB, F3, FABP3, FABP4, HSPA1A, IGF1R, INSR, KDR, MET, MMP9, NUAK1, PPARA, PTPN1, RORC, SMAD3, SRC, TEK, TNKS, TNKS2, XDH |
2.34195 |
[BP] GO:0050727 |
regulation of inflammatory response
|
ADORA1, CYP19A1, EGFR, ESR1, FABP4, PPARA, SMAD3, TEK |
2.33239 |
[BP] GO:0006807 |
nitrogen compound metabolic process
|
ACHE, AKR1B1, AKR1B10, ALPL, AOX1, APP, BCL2, CDC25B, CDK6, CSNK2A1, CYP1A1, CYP1A2, CYP1B1, CYP3A4, DRD1, DRD2, DUSP3, EGFR, ESR1, ESR2, ESRRA, ESRRB, F10, F3, FUT7, GBA2, HSPA1A, IGF1R, INSR, KDR, MET, MMP1, MMP2, MMP9, NUAK1, PPARA, PTPN1, PTPRS, RORC, SMAD3, SRC, TEK, TNKS, TNKS2, TYR, XDH |
2.32555 |
[BP] GO:0055080 |
cation homeostasis
|
APP, BCL2, CA2, CA7, DRD1, DRD2, EGFR, ESR1, GPR35, SMAD3 |
2.31879 |
[BP] GO:0010675 |
None
|
ESRRB, INSR, PPARA, RORC, SRC |
2.31121 |
[BP] GO:0031401 |
positive regulation of protein modification process
|
ADORA1, ALOX15, APP, BCL2, CDC25B, DRD2, EGFR, INSR, KDR, MMP9, PTPN1, SRC, TEK, XDH |
2.30521 |
[BP] GO:0009404 |
toxin metabolic process
|
CYP1A1, CYP1A2, CYP1B1 |
2.29675 |
[BP] GO:0060255 |
regulation of macromolecule metabolic process
|
ACHE, ADORA1, ADORA3, ALOX15, APP, BCL2, CA9, CDC25B, CDK6, CSNK2A1, CYP1A2, CYP1B1, DRD1, DRD2, DUSP3, EGFR, ESR1, ESR2, ESRRA, ESRRB, F3, FABP4, HSPA1A, IGF1R, INSR, KDR, MET, MMP9, NUAK1, PPARA, PTPN1, RORC, SMAD3, SRC, TEK, TNKS, TNKS2, XDH |
2.29395 |
[BP] GO:0071417 |
cellular response to organonitrogen compound
|
AKR1B1, APP, DRD1, EGFR, IGF1R, INSR, MMP2, SRC |
2.29325 |
[BP] GO:0070213 |
None
|
TNKS, TNKS2 |
2.29325 |
[BP] GO:0006145 |
None
|
AOX1, XDH |
2.29325 |
[BP] GO:0018894 |
dibenzo-p-dioxin metabolic process
|
CYP1A1, CYP1A2 |
2.29325 |
[BP] GO:0009894 |
regulation of catabolic process
|
ADORA1, BCL2, CSNK2A1, EGFR, ESRRB, HSPA1A, INSR, KDR, MET, PPARA, PTPN1, SMAD3 |
2.27747 |
[BP] GO:0050805 |
negative regulation of synaptic transmission
|
ACHE, ADORA1, DRD1, DRD2 |
2.27747 |
[BP] GO:0010634 |
positive regulation of epithelial cell migration
|
KDR, MET, MMP9, SRC, TEK |
2.26387 |
[BP] GO:0051894 |
None
|
KDR, SMAD3, TEK |
2.26084 |
[BP] GO:1903409 |
reactive oxygen species biosynthetic process
|
CYP1A1, CYP1A2, CYP1B1 |
2.26084 |
[BP] GO:0006631 |
fatty acid metabolic process
|
ALOX15, CBR1, CYP1A1, CYP1A2, CYP1B1, FABP3, PPARA |
2.25964 |
[BP] GO:0044267 |
cellular protein metabolic process
|
ALPL, APP, BCL2, CDC25B, CDK6, CSNK2A1, DRD1, DUSP3, EGFR, ESR1, F10, FUT7, IGF1R, INSR, KDR, MET, MMP1, MMP2, NUAK1, PTPN1, PTPRS, SMAD3, SRC, TEK, TNKS, TNKS2 |
2.25797 |
[BP] GO:0006352 |
DNA-templated transcription, initiation
|
ESR1, ESR2, ESRRA, ESRRB, PPARA, RORC |
2.2452 |
[BP] GO:0043393 |
regulation of protein binding
|
APP, BCL2, MET, MMP9, PPARA, SRC |
2.2452 |
[BP] GO:0046486 |
glycerolipid metabolic process
|
ACHE, ALOX15, CSNK2A1, DRD2, EGFR, FABP3, FABP4, MET |
2.245 |
[BP] GO:0043281 |
regulation of cysteine-type endopeptidase activity involved in apoptotic process
|
CSNK2A1, F3, MMP9, SMAD3, SRC, XDH |
2.23625 |
[BP] GO:0050927 |
None
|
F3, KDR, SMAD3 |
2.21587 |
[BP] GO:0040014 |
regulation of multicellular organism growth
|
APP, BCL2, DRD2, TNKS2 |
2.21583 |
[BP] GO:0045859 |
regulation of protein kinase activity
|
ADORA1, APP, CDC25B, DRD2, DUSP3, EGFR, FABP4, IGF1R, INSR, PTPN1, SRC |
2.21421 |
[BP] GO:0008283 |
cell proliferation
|
ABCB1, ACHE, BCL2, CYP1A1, EGFR, ESR1, MET, SRC, TEK, TYR |
2.213 |
[BP] GO:0006464 |
cellular protein modification process
|
ALPL, APP, BCL2, CDC25B, CDK6, CSNK2A1, DRD1, DUSP3, EGFR, ESR1, F10, FUT7, IGF1R, INSR, KDR, MET, NUAK1, PTPN1, PTPRS, SMAD3, SRC, TEK, TNKS, TNKS2 |
2.19978 |
[BP] GO:0036211 |
protein modification process
|
ALPL, APP, BCL2, CDC25B, CDK6, CSNK2A1, DRD1, DUSP3, EGFR, ESR1, F10, FUT7, IGF1R, INSR, KDR, MET, NUAK1, PTPN1, PTPRS, SMAD3, SRC, TEK, TNKS, TNKS2 |
2.19978 |
[BP] GO:0045913 |
None
|
ESRRB, INSR, PPARA, SRC |
2.19978 |
[BP] GO:0006706 |
steroid catabolic process
|
CYP19A1, CYP1A2, CYP3A4 |
2.17817 |
[BP] GO:0050926 |
None
|
F3, KDR, SMAD3 |
2.17817 |
[BP] GO:1903393 |
None
|
KDR, SMAD3, TEK |
2.17817 |
[BP] GO:0051054 |
positive regulation of DNA metabolic process
|
EGFR, IGF1R, INSR, SRC, TNKS, TNKS2 |
2.17355 |
[BP] GO:0072507 |
divalent inorganic cation homeostasis
|
APP, BCL2, DRD1, DRD2, EGFR, ESR1, GPR35, SMAD3 |
2.1622 |
[BP] GO:0007416 |
None
|
ACHE, APP, DRD1, DRD2 |
2.15834 |
[BP] GO:0035239 |
tube morphogenesis
|
BCL2, EGFR, ESR1, MET, SMAD3, SRC |
2.15642 |
[BP] GO:0032872 |
regulation of stress-activated MAPK cascade
|
APP, DUSP3, EGFR, IGF1R, PTPN1, XDH |
2.15642 |
[BP] GO:0070302 |
regulation of stress-activated protein kinase signaling cascade
|
APP, DUSP3, EGFR, IGF1R, PTPN1, XDH |
2.14792 |
[BP] GO:1904357 |
None
|
SRC, TNKS, TNKS2 |
2.13834 |
[BP] GO:0048545 |
response to steroid hormone
|
ALPL, BCL2, CA2, EGFR, HSD11B2, SRC |
2.13091 |
[BP] GO:0021853 |
None
|
DRD1, DRD2 |
2.13091 |
[BP] GO:0043696 |
None
|
CDK6, ESRRB |
2.13091 |
[BP] GO:0043697 |
None
|
CDK6, ESRRB |
2.13091 |
[BP] GO:0010641 |
None
|
F3, SRC |
2.13091 |
[BP] GO:0007598 |
None
|
F10, F3 |
2.13091 |
[BP] GO:1904936 |
None
|
DRD1, DRD2 |
2.13091 |
[BP] GO:0042321 |
None
|
ADORA1, DRD2 |
2.13091 |
[BP] GO:1901699 |
cellular response to nitrogen compound
|
AKR1B1, APP, DRD1, EGFR, IGF1R, INSR, MMP2, SRC |
2.11639 |
[BP] GO:0008209 |
androgen metabolic process
|
CYP19A1, CYP3A4, ESR1 |
2.10875 |
[BP] GO:0032868 |
None
|
FABP3, HSD11B2, INSR, PPARA, SRC |
2.10512 |
[BP] GO:0071495 |
cellular response to endogenous stimulus
|
AKR1B1, APP, DRD1, EGFR, ESR1, IGF1R, INSR, MMP2, SMAD3, SRC |
2.10052 |
[BP] GO:0001101 |
response to acid chemical
|
AKR1B1, EGFR, FABP3, HSD17B2, KDR, MMP2, SRC |
2.08971 |
[BP] GO:0043271 |
negative regulation of ion transport
|
ADORA1, BCL2, DRD2, GPR35, MMP9 |
2.0811 |
[BP] GO:0031334 |
positive regulation of protein complex assembly
|
ALOX15, ESR1, HSPA1A, MET, MMP1, SRC |
2.07924 |
[BP] GO:0065007 |
biological regulation
|
ABCB1, ACHE, ADORA1, ADORA3, AKR1B1, ALOX15, APP, BCL2, CA1, CA12, CA2, CA7, CA9, CDC25B, CDK6, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP3A4, DRD1, DRD2, DUSP3, EGFR, ESR1, ESR2, ESRRA, ESRRB, F10, F3, FABP3, FABP4, GPR35, HSD11B1, HSD11B2, HSD17B1, HSD17B2, HSPA1A, IGF1R, INSR, KDR, MET, MMP1, MMP2, MMP9, NUAK1, PPARA, PTPN1, PTPRS, RORC, SMAD3, SRC, TEK, TNKS, TNKS2, XDH |
2.07476 |
[BP] GO:0048661 |
positive regulation of smooth muscle cell proliferation
|
AKR1B1, EGFR, MMP2, MMP9 |
2.05732 |
[BP] GO:0034762 |
None
|
ABCB1, APP, BCL2, CA2, DRD1, DRD2, GPR35, MMP9 |
2.05625 |
[BP] GO:0022898 |
None
|
ABCB1, APP, BCL2, DRD2, GPR35, MMP9 |
2.05497 |
[BP] GO:0045931 |
positive regulation of mitotic cell cycle
|
APP, CDC25B, CYP1A1, DUSP3, INSR |
2.04767 |
[BP] GO:0042060 |
None
|
ALOX15, EGFR, PPARA, SMAD3 |
2.03997 |
[BP] GO:0050678 |
None
|
CDK6, EGFR, F3, KDR, SMAD3, TEK, XDH |
2.039 |
[BP] GO:0035265 |
organ growth
|
BCL2, CYP19A1, ESR1 |
2.039 |
[BP] GO:0042743 |
hydrogen peroxide metabolic process
|
CYP1A1, CYP1A2, EGFR |
2.039 |
[BP] GO:0030003 |
cellular cation homeostasis
|
APP, BCL2, CA2, CA7, DRD1, DRD2, ESR1, GPR35, SMAD3 |
2.03521 |
[BP] GO:0051254 |
None
|
APP, DRD2, EGFR, ESR1, ESR2, ESRRA, ESRRB, HSPA1A, INSR, MET, PPARA, RORC, SMAD3, SRC, TNKS |
2.023 |
[BP] GO:1901890 |
None
|
KDR, SMAD3, TEK |
2.0041 |
[BP] GO:0071276 |
cellular response to cadmium ion
|
CYP1A2, EGFR, MMP9 |
2.0041 |
[BP] GO:0001659 |
None
|
ADORA1, DRD1, DRD2 |
2.0041 |
[BP] GO:0010039 |
response to iron ion
|
BCL2, CYP1A1, DRD2 |
2.0041 |
[BP] GO:0009653 |
anatomical structure morphogenesis
|
APP, BCL2, CA2, CA9, CYP1B1, DRD2, EGFR, ESR1, INSR, MET, MMP2, SMAD3, SRC, TEK |
2.0041 |
[BP] GO:0040007 |
None
|
APP, BCL2, CYP19A1, ESR1, SMAD3, SRC, TNKS2 |
2.0041 |
[BP] GO:0008217 |
None
|
ADORA1, DRD2, HSD11B2, PPARA, SMAD3 |
2.0041 |
[BP] GO:0021843 |
None
|
DRD1, DRD2 |
2.0041 |
[BP] GO:0051902 |
negative regulation of mitochondrial depolarization
|
BCL2, SRC |
2.0041 |
[BP] GO:0046113 |
None
|
AOX1, XDH |
2.0041 |
[BP] GO:1990535 |
None
|
APP, INSR |
2.0041 |
[BP] GO:0021830 |
None
|
DRD1, DRD2 |
2.0041 |
[BP] GO:0002933 |
lipid hydroxylation
|
CYP1A1, CYP3A4 |
2.0041 |
[BP] GO:0021826 |
None
|
DRD1, DRD2 |
2.0041 |
[BP] GO:0016098 |
monoterpenoid metabolic process
|
CYP1A2, CYP3A4 |
2.0041 |
[BP] GO:2000116 |
regulation of cysteine-type endopeptidase activity
|
CSNK2A1, F3, MMP9, SMAD3, SRC, XDH |
2.0041 |
[CC] GO:0043227 |
membrane-bounded organelle
|
ABCB1, ACHE, ADORA1, AKR1B1, AKR1B10, ALPL, AOX1, APP, BCL2, CA1, CA2, CA4, CA6, CBR1, CDK6, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP3A4, DRD1, DRD2, DUSP3, EGFR, ESR1, ESR2, ESRRA, ESRRB, F3, FABP3, FABP4, FUT7, GBA2, HSPA1A, IGF1R, INSR, KDR, MMP2, MMP9, NUAK1, PPARA, PTPN1, PTPRS, RORC, SMAD3, SRC, TNKS, TNKS2, TUBB3, TYR, XDH |
2.6341 |
[CC] GO:0005886 |
plasma membrane
|
ABCB1, ACHE, ADORA1, ADORA3, ALOX15, ALPL, APP, CA12, CA14, CA2, CA4, CA9, CSNK2A1, DRD1, DRD2, EGFR, ESR1, F10, F3, GBA2, GPR35, IGF1R, INSR, KDR, MET, MMP2, PTPN1, PTPRS, SMAD3, SRC, TEK |
2.55062 |
[CC] GO:0044432 |
endoplasmic reticulum part
|
APP, BCL2, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP3A4, DRD1, EGFR, F10, GBA2, HSD11B1, HSD11B2, HSD17B2, PTPN1 |
2.53254 |
[CC] GO:0031233 |
None
|
CA4, F10, F3 |
2.44108 |
[CC] GO:0016323 |
basolateral plasma membrane
|
ADORA1, CA2, CA4, CA9, EGFR, TEK |
2.42014 |
[CC] GO:0044425 |
membrane part
|
ABCB1, ACHE, ADORA1, ADORA3, ALOX15, ALPL, APP, BCL2, CA12, CA14, CA2, CA4, CA9, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP3A4, DRD1, DRD2, DUSP3, EGFR, ESR1, F10, F3, FUT7, GBA2, GPR35, HSD11B1, HSD11B2, HSD17B2, IGF1R, INSR, KDR, MET, PTPN1, PTPRS, SRC, TEK, TYR |
2.39688 |
[CC] GO:0016020 |
membrane
|
ABCB1, ACHE, ADORA1, ADORA3, ALOX15, ALPL, APP, BCL2, CA12, CA14, CA2, CA4, CA9, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP3A4, DRD1, DRD2, EGFR, ESR1, F10, F3, FUT7, GBA2, GPR35, HSD11B1, HSD11B2, HSD17B2, IGF1R, INSR, KDR, MET, MMP2, PTPN1, PTPRS, SMAD3, SRC, TEK, TNKS, TNKS2, TYR |
2.37975 |
[CC] GO:0005789 |
endoplasmic reticulum membrane
|
BCL2, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP3A4, DRD1, EGFR, GBA2, HSD11B1, HSD11B2, HSD17B2 |
2.26222 |
[CC] GO:0043226 |
organelle
|
ABCB1, ACHE, ADORA1, AKR1B1, AKR1B10, ALOX15, ALPL, AOX1, APP, BCL2, CA1, CA2, CA4, CA6, CA9, CBR1, CDK6, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP3A4, DRD1, DRD2, DUSP3, EGFR, ESR1, ESR2, ESRRA, ESRRB, F3, FABP3, FABP4, FUT7, GBA2, HSPA1A, IGF1R, INSR, KDR, MMP2, MMP9, NUAK1, PPARA, PTPN1, PTPRS, RORC, SMAD3, SRC, TNKS, TNKS2, TUBB3, TYR, XDH |
2.14999 |
[CC] GO:0044459 |
plasma membrane part
|
ABCB1, ADORA1, ADORA3, ALOX15, APP, CA2, CA4, CA9, DRD1, DRD2, DUSP3, EGFR, F10, F3, GPR35, IGF1R, INSR, KDR, MET, PTPRS, SRC, TEK |
2.13814 |
[CC] GO:0031253 |
None
|
ADORA1, CA4, CA9, DRD1, DRD2, INSR, SRC |
2.13091 |
[CC] GO:0044444 |
cytoplasmic part
|
ACHE, ADORA1, AKR1B1, AKR1B10, ALOX15, AOX1, APP, BCL2, CA1, CA2, CA4, CA7, CBR1, CDC25B, CDK6, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP3A4, DRD1, DRD2, DUSP3, EGFR, ESR1, ESR2, F10, FABP3, FABP4, FUT7, GBA2, HSD11B1, HSD11B2, HSD17B1, HSD17B2, HSPA1A, INSR, KDR, MMP2, MMP9, PTPN1, PTPRS, SMAD3, SRC, TNKS, TNKS2, TYR, XDH |
2.10512 |
[CC] GO:0098590 |
plasma membrane region
|
ABCB1, ADORA1, CA2, CA4, CA9, DRD1, DRD2, EGFR, INSR, MET, SRC, TEK |
2.06932 |
[CC] GO:0031226 |
intrinsic component of plasma membrane
|
ADORA1, ADORA3, APP, CA4, DRD1, DRD2, F10, F3, GPR35, IGF1R, INSR, KDR, MET, PTPRS, TEK |
2.06009 |
[CC] GO:0097443 |
sorting endosome
|
KDR, PTPN1 |
2.0041 |
[MF] GO:0046914 |
transition metal ion binding
|
ALOX15, AOX1, APP, CA1, CA12, CA2, CA4, CA6, CA7, CA9, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP3A4, ESR1, ESR2, ESRRA, ESRRB, MMP1, MMP2, MMP9, PPARA, PTPN1, RORC, SMAD3, TNKS, TYR, XDH |
14.0166 |
[MF] GO:0004089 |
carbonate dehydratase activity
|
CA1, CA12, CA14, CA2, CA4, CA6, CA7, CA9 |
11.9754 |
[MF] GO:0043167 |
ion binding
|
ABCB1, ACHE, ALOX15, ALPL, AOX1, APP, CA1, CA12, CA14, CA2, CA4, CA6, CA7, CA9, CDK6, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP3A4, DRD1, DRD2, EGFR, ESR1, ESR2, ESRRA, ESRRB, F10, F3, FABP3, FABP4, HSD17B1, HSPA1A, IGF1R, INSR, KDR, MET, MMP1, MMP2, MMP9, NUAK1, PPARA, PTPN1, PTPRS, RORC, SMAD3, SRC, TEK, TNKS, TNKS2, TUBB3, TYR, XDH |
11.2523 |
[MF] GO:0003824 |
catalytic activity
|
ABCB1, ACHE, ADORA1, AKR1B1, AKR1B10, ALOX15, ALPL, AOX1, CA1, CA12, CA14, CA2, CA4, CA6, CA7, CA9, CBR1, CDC25B, CDK6, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP3A4, DUSP3, EGFR, F10, F3, FUT7, GBA2, HSD11B1, HSD11B2, HSD17B1, HSD17B2, HSPA1A, IGF1R, INSR, KDR, MET, MMP1, MMP2, MMP9, NUAK1, PTPN1, PTPRS, SRC, TEK, TNKS, TNKS2, TUBB3, TYR, XDH |
11.1887 |
[MF] GO:0016836 |
hydro-lyase activity
|
CA1, CA12, CA14, CA2, CA4, CA6, CA7, CA9 |
7.77076 |
[MF] GO:0008270 |
zinc ion binding
|
CA1, CA12, CA2, CA4, CA6, CA7, CA9, ESR1, ESR2, ESRRA, ESRRB, MMP1, MMP2, MMP9, PPARA, PTPN1, RORC, SMAD3, TNKS |
7.5932 |
[MF] GO:0016835 |
carbon-oxygen lyase activity
|
CA1, CA12, CA14, CA2, CA4, CA6, CA7, CA9 |
6.8192 |
[MF] GO:0005496 |
steroid binding
|
CYP3A4, ESR1, ESR2, ESRRA, ESRRB, HSD11B2, HSD17B1, RORC |
6.49665 |
[MF] GO:0016614 |
oxidoreductase activity, acting on CH-OH group of donors
|
AKR1B1, AKR1B10, AOX1, CBR1, HSD11B1, HSD11B2, HSD17B1, HSD17B2, XDH |
6.31705 |
[MF] GO:0016491 |
oxidoreductase activity
|
AKR1B1, AKR1B10, ALOX15, AOX1, CBR1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP3A4, HSD11B1, HSD11B2, HSD17B1, HSD17B2, TYR, XDH |
5.88757 |
[MF] GO:0043169 |
cation binding
|
ACHE, ALOX15, ALPL, AOX1, APP, CA1, CA12, CA14, CA2, CA4, CA6, CA7, CA9, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP3A4, DRD1, DRD2, ESR1, ESR2, ESRRA, ESRRB, F10, MMP1, MMP2, MMP9, NUAK1, PPARA, PTPN1, RORC, SMAD3, TNKS, TNKS2, TYR, XDH |
5.81398 |
[MF] GO:0070330 |
aromatase activity
|
CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP3A4 |
5.32099 |
[MF] GO:0098531 |
transcription factor activity, direct ligand regulated sequence-specific DNA binding
|
ESR1, ESR2, ESRRA, ESRRB, PPARA, RORC |
5.23157 |
[MF] GO:0004879 |
nuclear receptor activity
|
ESR1, ESR2, ESRRA, ESRRB, PPARA, RORC |
5.23157 |
[MF] GO:0016712 |
oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygen
|
CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP3A4 |
5.08172 |
[MF] GO:0003707 |
steroid hormone receptor activity
|
ESR1, ESR2, ESRRA, ESRRB, PPARA, RORC |
4.83649 |
[MF] GO:0008289 |
lipid binding
|
ALOX15, CYP3A4, ESR1, ESR2, ESRRA, ESRRB, F10, F3, FABP3, FABP4, HSD11B2, HSD17B1, PPARA, RORC |
4.72831 |
[MF] GO:0004714 |
transmembrane receptor protein tyrosine kinase activity
|
EGFR, IGF1R, INSR, KDR, MET, TEK |
4.72743 |
[MF] GO:0005506 |
iron ion binding
|
ALOX15, AOX1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP3A4, XDH |
4.68472 |
[MF] GO:0016616 |
oxidoreductase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor
|
AKR1B1, AKR1B10, CBR1, HSD11B1, HSD11B2, HSD17B1, HSD17B2 |
4.38155 |
[MF] GO:0046872 |
metal ion binding
|
ALOX15, ALPL, AOX1, APP, CA1, CA12, CA14, CA2, CA4, CA6, CA7, CA9, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP3A4, ESR1, ESR2, ESRRA, ESRRB, F10, MMP1, MMP2, MMP9, NUAK1, PPARA, PTPN1, RORC, SMAD3, TNKS, TNKS2, TYR, XDH |
4.31618 |
[MF] GO:0008144 |
drug binding
|
ABCB1, ACHE, CDK6, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP3A4, DRD1, DRD2, EGFR, HSPA1A, IGF1R, INSR, KDR, MET, NUAK1, PPARA, SRC, TEK |
4.2854 |
[MF] GO:0016829 |
lyase activity
|
CA1, CA12, CA14, CA2, CA4, CA6, CA7, CA9 |
4.2854 |
[MF] GO:0019199 |
transmembrane receptor protein kinase activity
|
EGFR, IGF1R, INSR, KDR, MET, TEK |
4.18469 |
[MF] GO:0019825 |
oxygen binding
|
CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP3A4 |
4.05137 |
[MF] GO:0038023 |
signaling receptor activity
|
ADORA1, ADORA3, DRD1, DRD2, EGFR, ESR1, ESR2, ESRRA, ESRRB, F3, GPR35, IGF1R, INSR, KDR, MET, PPARA, RORC, TEK |
3.85437 |
[MF] GO:0004497 |
monooxygenase activity
|
CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP3A4, TYR |
3.77836 |
[MF] GO:0060089 |
molecular transducer activity
|
ADORA1, ADORA3, CDK6, DRD1, DRD2, EGFR, ESR1, ESR2, ESRRA, ESRRB, F3, GPR35, IGF1R, INSR, KDR, MET, PPARA, RORC, TEK |
3.59685 |
[MF] GO:0033764 |
steroid dehydrogenase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor
|
HSD11B1, HSD11B2, HSD17B1, HSD17B2 |
3.48709 |
[MF] GO:0016229 |
steroid dehydrogenase activity
|
HSD11B1, HSD11B2, HSD17B1, HSD17B2 |
3.37177 |
[MF] GO:0004713 |
protein tyrosine kinase activity
|
EGFR, IGF1R, INSR, KDR, MET, SRC, TEK |
3.34775 |
[MF] GO:0016725 |
oxidoreductase activity, acting on CH or CH2 groups
|
CYP1A2, CYP3A4, XDH |
3.34401 |
[MF] GO:0004716 |
signal transducer, downstream of receptor, with protein tyrosine kinase activity
|
EGFR, INSR, KDR |
3.34401 |
[MF] GO:0004871 |
signal transducer activity
|
ADORA1, ADORA3, DRD1, DRD2, EGFR, ESR1, ESR2, ESRRA, ESRRB, F3, GPR35, IGF1R, INSR, KDR, MET, PPARA, RORC, SMAD3, TEK |
3.24884 |
[MF] GO:0004872 |
receptor activity
|
ADORA1, ADORA3, DRD1, DRD2, EGFR, ESR1, ESR2, ESRRA, ESRRB, F3, GPR35, IGF1R, INSR, KDR, MET, PPARA, RORC, TEK |
3.23674 |
[MF] GO:0020037 |
heme binding
|
CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP3A4, SRC |
3.15995 |
[MF] GO:0048037 |
cofactor binding
|
AOX1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP3A4, HSD11B2, HSD17B1, SRC, XDH |
3.10381 |
[MF] GO:0046906 |
tetrapyrrole binding
|
CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP3A4, SRC |
2.99886 |
[MF] GO:0038052 |
RNA polymerase II transcription factor activity, estrogen-activated sequence-specific DNA binding
|
ESR1, ESR2 |
2.89496 |
[MF] GO:0003845 |
None
|
HSD11B1, HSD11B2 |
2.89496 |
[MF] GO:0042562 |
hormone binding
|
ACHE, EGFR, HSD17B1, IGF1R, INSR |
2.89496 |
[MF] GO:0016903 |
None
|
AKR1B1, AKR1B10, AOX1, XDH |
2.77027 |
[MF] GO:0016705 |
oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen
|
CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP3A4, TYR |
2.76106 |
[MF] GO:0032403 |
protein complex binding
|
ACHE, ADORA1, EGFR, ESRRB, IGF1R, INSR, KDR, MMP9, PPARA, PTPN1, SMAD3, SRC |
2.7341 |
[MF] GO:0019902 |
phosphatase binding
|
BCL2, EGFR, MET, PPARA, PTPN1, SMAD3 |
2.64905 |
[MF] GO:0043168 |
anion binding
|
ABCB1, ALOX15, AOX1, APP, CDK6, CSNK2A1, EGFR, F10, F3, FABP3, FABP4, HSD17B1, HSPA1A, IGF1R, INSR, KDR, MET, NUAK1, PTPRS, SRC, TEK, TUBB3, XDH |
2.54776 |
[MF] GO:0044877 |
macromolecular complex binding
|
ACHE, ADORA1, CSNK2A1, EGFR, ESRRB, IGF1R, INSR, KDR, MMP9, PPARA, PTPN1, SMAD3, SRC |
2.52417 |
[MF] GO:0070576 |
vitamin D 24-hydroxylase activity
|
CYP1A1, CYP3A4 |
2.51578 |
[MF] GO:0009055 |
electron transfer activity
|
AKR1B1, AOX1, CYP19A1, CYP1A2, XDH |
2.4951 |
[MF] GO:0019899 |
enzyme binding
|
APP, BCL2, CDC25B, CYP1A1, CYP1A2, CYP3A4, DUSP3, EGFR, ESR1, ESR2, ESRRB, F3, HSPA1A, MET, PPARA, PTPN1, SMAD3, SRC, TEK, TNKS2 |
2.47441 |
[MF] GO:0034056 |
estrogen response element binding
|
ESR1, ESR2 |
2.29325 |
[MF] GO:0034875 |
caffeine oxidase activity
|
CYP1A2, CYP3A4 |
2.29325 |
[MF] GO:0051425 |
None
|
APP, INSR |
2.29325 |
[MF] GO:0033695 |
oxidoreductase activity, acting on CH or CH2 groups, quinone or similar compound as acceptor
|
CYP1A2, CYP3A4 |
2.29325 |
[MF] GO:0004672 |
protein kinase activity
|
CDK6, CSNK2A1, EGFR, IGF1R, INSR, KDR, MET, NUAK1, SRC, TEK |
2.21583 |
[MF] GO:0019838 |
growth factor binding
|
EGFR, IGF1R, INSR, KDR, TEK |
2.20342 |
[MF] GO:0101020 |
estrogen 16-alpha-hydroxylase activity
|
CYP1A1, CYP3A4 |
2.13091 |
[MF] GO:0030284 |
estrogen receptor activity
|
ESR1, ESR2 |
2.13091 |
[MF] GO:0043559 |
insulin binding
|
IGF1R, INSR |
2.13091 |
[MF] GO:0042802 |
identical protein binding
|
ACHE, AOX1, APP, BCL2, CSNK2A1, DRD2, EGFR, ESR1, ESR2, IGF1R, KDR, MET, MMP9, SMAD3, TYR, XDH |
2.10052 |
[MF] GO:0005158 |
None
|
IGF1R, PTPN1, SRC |
2.0041 |
[MF] GO:0004064 |
arylesterase activity
|
CA1, CA2 |
2.0041 |
[MF] GO:0043546 |
None
|
AOX1, XDH |
2.0041 |